Updated 06:01 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 16.91 -3.48% GOLD 4,040.30 -0.28% CL 101.33 -1.41% BTC 80,120.34 -0.85%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,040 −0.28% BTC $80,120 −0.85% VIX 16.91 −3.48% latest tape · as of 06:01 UTC
The Screen · Communication Services

NEXON Co., Ltd.

NEXOY · PNK · USD · Market cap $13.6B

FAIL · Does not pass the screen
17.64 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago

Screened 2026-10-23 · the tape above runs as of 06:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price17.64 USD at the 23 Oct 2026 close
  • Our ratingAvoid, current read distribution
  • Ethical screenDoes not pass
  • Last reviewed23 Oct 2026 (6 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 17.64 against the desk's fair-value range, over the last year.

Current read
Distribution ?
AVOID · screened 2026-10-23
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price17.64 USD
RatingAVOID
Our investment reviews on this name
2026-10-11Read Distribution16.78+5.1% to today Markdown gives way to Distribution first Distribution read since July
2026-10-02Read Markdown16.78+5.1% to today Markup gives way to Markdown while volume still accumulates
2026-08-06Read Markup16.20+8.9% to today ✓Distribution gives way to Markup after a 17% rise in 5 weeks
2026-07-02Read Distribution13.80+27.8% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

NEXON Co., Ltd. holds its Distribution at $17.64. Consolidating, no directional conviction, held for 18 days.

As held on the ledger · 2026-10-23
PhaseDistribution · caution
Quantitative stateConsolidating, no directional conviction, held for 18 days
Price at the screen$17.64
Valuation15.68 trailing · N/A forward price to earnings
Values screenFAIL
Beta0.57
The Workings

Five Screens, Shown in Full

Does not pass. Interest/revenue 7.8%

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 0.00% Below 33% Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 7.84% Below 5% 7.8% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

NEXON does not pass the ethical screen. The binding factor is interest/revenue 7.8%.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

2026-10-25 Does not pass

NEXON does not pass the ethical screen. The binding factor is interest/revenue 7.8%.

2026-09-24 Clears

NEXON clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.

Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.

Follow this verdict

Get an email when NEXOY's ethical verdict changes

Today NEXOY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads AVOID: 1.90% revenue growth.

Price History & Projections
$25.7$19.2$12.6TODAY5y agoPROJECTION

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

On our numbers, the price already runs ahead of the business.

The fundamentals · plain-English read
Trailing P/E15.7xreasonably valued
EPS, trailing1.11
Revenue growth+1.9%slow but positive growth
Profit margin26.4%healthy profit margins
Return on equity12.5%a solid return on shareholder capital
FCF yield811.42%
Dividend yield190.00%
Debt to equity4.55heavy leverage: higher risk if revenue softens
Current ratio5.85comfortably covers its short-term bills
Beta0.57steadier than the market
52-week range13.01 - 28.82
Market cap$13.6B

The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

NEXOY trades on PNK. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-26 Distribution $17.41 +3.8% Entry 8

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.

2026-10-11 Distribution · changed $16.78 +0.0% Entry 7

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.

2026-10-02 Markdown · changed $16.78 -13.9% Entry 6

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 13.9% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%. Since the last review it dropped out of the Tech 100.

2026-09-06 Markup $19.49 +20.3% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 20.3% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.

2026-08-06 Markup · changed $16.20 +17.4% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 17.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.

2026-07-18 Distribution $13.80 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 22%.

2026-07-03 Distribution $13.80 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Distribution $13.80 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on NEXOY

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in NEXOY's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $17.10 -20.8% · $792 -20.8%
2 months $16.75 -19.2% · $808 -19.2%
3 months $19.00 -28.7% · $713 -28.7%
6 months $24.82 -45.5% · $546 -45.5%
1 year $18.04 -24.9% · $751 -24.9%
2 years $17.52 -22.7% $0.10 $778 -22.2%
3 years $20.34 -33.4% $0.10 $671 -32.9%
5 years $22.78 -40.6% $0.10 $599 -40.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever NEXOY does next, these words stay.

NEXON Co., Ltd. · NEXOY · Distribution · $17.64
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.